Endocrine Sensitive HER2+/HR+ Breast Cancer
1 clinical trials · Condition
◉ Watch Endocrine Sensitive HER2+/HR+ Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy (NCT02411344) | Istituto Oncologico Veneto IRCCS | 2014-02-01 |
Track Endocrine Sensitive HER2+/HR+ Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.